Evaluation of the efficacy of lipotransfer to manage radiation‐induced fibrosis and volume defects in head and neck oncology

Background Multimodality treatment for head and neck cancer leads to substantial functional and esthetic impairment mainly manifested as radiation‐induced skin fibrosis (RIF) in combination with volumetric defects and reduction in neck mobility. This study assessed the impact of lipotransfer as part...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Head & neck 2019-10, Vol.41 (10), p.3647-3655
Hauptverfasser: Griffin, Michelle F., Drago, Jelovac, Almadori, Aurora, Kalavrezos, Nicholas, Butler, Peter E.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background Multimodality treatment for head and neck cancer leads to substantial functional and esthetic impairment mainly manifested as radiation‐induced skin fibrosis (RIF) in combination with volumetric defects and reduction in neck mobility. This study assessed the impact of lipotransfer as part of secondary surgical procedure(s) in patients treated for head and neck malignancies. Methods Retrospective analysis was performed between 2005 and 2016. All patients with a history of head and neck malignancy, multimodal treatment including at least surgery or radiotherapy, and at least 2‐year disease‐free survival were included. Thirty‐eight patients (22 men, 16 women) matched the inclusion criteria. Results Thirty seven (97%) reported esthetic and functional improvements in their RIF and volumetric defect at follow‐up of 32 months. Major improvement in esthetic and functional outcome was reported by 24 (63%) patients and surgeons and minor by 13 patients and surgeons (34%) without causing any complications. Lipotransfer was also found to significantly improve patient's psychological health postoperatively as showed by significant improvements in Derriford Appearance Scale (DAS24), Short Form Health Survey (SF‐36), and University of Washington Quality of Life Questionnaire (UW‐QOL V4) scores (P
ISSN:1043-3074
1097-0347
DOI:10.1002/hed.25888